{
  "simulation_id": "sim_20250503_022152",
  "config": {
    "use_team_leadership": false,
    "use_closed_loop_comm": false,
    "use_mutual_monitoring": false,
    "use_shared_mental_model": false,
    "use_team_orientation": false,
    "use_mutual_trust": true,
    "mutual_trust_factor": 0.9,
    "use_recruitment": false,
    "recruitment_method": "advanced",
    "recruitment_pool": "general",
    "random_leader": false,
    "task": "Autoimmune Encephalitis Diagnosis"
  },
  "exchanges": [
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Critical Analyst",
      "message": "**B. Anti-LGI1 antibodies**\n\n### Final Rationale:\nAfter integrating my analysis with the perspectives of my teammates, the most consistent diagnosis is **anti-LGI1 antibody-associated encephalitis**. Key reasons include:\n\n1. **Clinical Presentation**:\n   - Subacute onset of memory deficits, confusion, and behavioral changes is a hallmark of limbic encephalitis, which is strongly associated with anti-LGI1 antibodies.\n\n2. **MRI Findings**:\n   - Bilateral medial temporal lobe hyperintensities are classic for anti-LGI1 encephalitis, making this condition the most likely among the options.\n\n3. **CSF and EEG Findings**:\n   - Mild lymphocytic pleocytosis in CSF and focal slowing in the temporal regions on EEG are both consistent with limbic encephalitis, particularly due to anti-LGI1 antibodies.\n\n4. **Exclusion of Other Options**:\n   - **Anti-NMDA receptor antibodies (Option A)**: Less likely because MRI findings of bilateral medial temporal lobe hyperintensities are not typical for anti-NMDA receptor encephalitis, which often has normal or nonspecific imaging findings. Additionally, other hallmark features of anti-NMDA receptor encephalitis (e.g., dyskinesias, autonomic instability) are absent.\n   - **Anti-GABA-B receptor antibodies (Option C)**: Less likely due to the patient\u2019s age (younger than typical for anti-GABA-B receptor encephalitis) and lack of evidence of a paraneoplastic syndrome.\n   - **Anti-AMPA receptor antibodies (Option D)**: Unlikely due to the rarity of this condition, its association with malignancies, and the lack of specific features aligning with this case.\n\n### Consensus:\nThe patient's clinical, radiological, and laboratory findings align most strongly with **anti-LGI1 antibody-associated encephalitis**, making **B** the correct answer."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Domain Expert",
      "message": "**B. Anti-LGI1 antibodies**\n\n### Final Rationale:\nAfter integrating the analyses from all team members, the consensus strongly supports **Anti-LGI1 antibodies** as the most likely cause of this patient's presentation. The key factors leading to this conclusion are:\n\n1. **Clinical Presentation**: The subacute onset of memory deficits, confusion, and behavioral changes is highly characteristic of limbic encephalitis, which is most commonly associated with anti-LGI1 antibodies.\n\n2. **MRI Findings**: Bilateral medial temporal lobe hyperintensities are a hallmark feature of anti-LGI1 encephalitis. While other autoimmune encephalitides can show similar findings, this radiological pattern is most strongly linked to anti-LGI1 antibodies.\n\n3. **CSF and EEG Findings**: Mild lymphocytic pleocytosis in the CSF and focal slowing in the temporal regions on EEG are consistent with anti-LGI1 encephalitis.\n\n4. **Demographic Considerations**: While anti-LGI1 encephalitis is more common in older males, it can also occur in younger females, as in this case. The absence of malignancy or other features typical of paraneoplastic syndromes further supports anti-LGI1 over other options.\n\n5. **Comparison with Other Options**:\n   - **Anti-NMDA receptor antibodies**: While common in young females, anti-NMDA receptor encephalitis typically involves diffuse cortical dysfunction, psychiatric symptoms, and movement abnormalities, which are not present here. MRI findings are often normal or nonspecific, making this less likely.\n   - **Anti-GABA-B receptor antibodies**: More common in older patients and frequently associated with malignancies, which are not noted here.\n   - **Anti-AMPA receptor antibodies**: Rare and typically linked to malignancies, making it less likely in this clinical context.\n\n### Conclusion:\nThe clinical, radiological, and laboratory findings align most strongly with **anti-LGI1 antibody-associated encephalitis**, making **B** the correct answer."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Creative Strategist",
      "message": "### Final Answer: **B. Anti-LGI1 antibodies**\n\n### Integrated Rationale:\nAfter reviewing the analyses from all team members and integrating their perspectives with my own expertise, **anti-LGI1 antibodies** remain the most likely cause of this patient\u2019s clinical presentation. Here\u2019s why:\n\n1. **Clinical Presentation**:\n   - The patient has subacute onset of **memory deficits, confusion, and behavioral changes**, which are hallmark features of **limbic encephalitis**. \n   - Anti-LGI1 encephalitis is a classic cause of limbic encephalitis, with a strong association with these symptoms.\n\n2. **MRI Findings**:\n   - **Bilateral medial temporal lobe hyperintensities** are a defining feature of limbic encephalitis and are **most strongly linked to anti-LGI1 antibodies**. While other antibodies (e.g., anti-GABA-B receptor) can also present with these findings, anti-LGI1 is the most common and fits this case better.\n\n3. **CSF and EEG Findings**:\n   - **Mild lymphocytic pleocytosis** in CSF and **focal slowing in the temporal regions** on EEG are consistent with anti-LGI1 encephalitis. These findings further support the diagnosis.\n\n4. **Demographics**:\n   - While anti-LGI1 encephalitis is more common in older adults, it can occur in younger individuals, especially in cases without strong paraneoplastic associations. This makes it plausible in this 32-year-old female.\n\n5. **Comparison with Other Options**:\n   - **Anti-NMDA receptor antibodies**: While common in younger females, the MRI findings (bilateral medial temporal lobe hyperintensities) are not characteristic of anti-NMDA receptor encephalitis, which often shows normal or nonspecific imaging.\n   - **Anti-GABA-B receptor antibodies**: This condition is more commonly associated with paraneoplastic syndromes and older patients, making it less likely here.\n   - **Anti-AMPA receptor antibodies**: Rare and more commonly linked to malignancies, making it the least likely option.\n\n### Consensus:\nThe analyses from all team members converge on **anti-LGI1 antibodies (Option B)** as the best answer. This decision is based on the clinical, imaging, and laboratory findings, which align most closely with **anti-LGI1 antibody-associated encephalitis**.\n\n**Final Answer**: **B**"
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Process Facilitator",
      "message": "**B. Anti-LGI1 antibodies**\n\n**Rationale:**  \nAfter integrating my initial analysis with the insights from my teammates, the most likely autoantibody associated with this clinical presentation is **anti-LGI1 antibodies**. The patient's symptoms of subacute memory deficits, confusion, and behavioral changes, along with **bilateral medial temporal lobe hyperintensities on MRI**, **mild lymphocytic pleocytosis in CSF**, and **focal slowing in the temporal regions on EEG**, strongly align with **anti-LGI1 antibody-associated limbic encephalitis**.  \n\nWhile anti-NMDA receptor encephalitis was initially considered due to the patient's age and symptom overlap, the MRI findings of bilateral medial temporal lobe hyperintensities are far more characteristic of anti-LGI1 encephalitis. Anti-GABA-B and anti-AMPA receptor encephalitides are less likely due to their association with older age groups or malignancies, which are not evident in this case.  \n\nConsensus among the team points to **anti-LGI1 antibodies** as the most fitting diagnosis, based on the clinical, imaging, and laboratory findings."
    }
  ],
  "decision_results": {
    "majority_voting": {
      "method": "majority_voting",
      "winning_option": "A",
      "vote_counts": {
        "A": 4
      },
      "total_votes": 4,
      "confidence": 1.0
    },
    "weighted_voting": {
      "method": "weighted_voting",
      "winning_option": "A",
      "weighted_votes": {
        "A": 2.8
      },
      "total_weight": 2.8,
      "confidence": 1.0
    },
    "borda_count": {
      "method": "borda_count",
      "winning_option": "A",
      "borda_scores": {
        "A": 12,
        "B": 8,
        "C": 4,
        "D": 0
      },
      "total_possible_score": 24.0,
      "confidence": 0.5
    }
  },
  "teamwork_metrics": {
    "mutual_trust": {
      "average_trust_level": 0.9034860589770829,
      "trust_network": {
        "Critical Analyst": {
          "Domain Expert": 0.8587429419170738,
          "Creative Strategist": 0.8364759111090597,
          "Process Facilitator": 0.8369250383510093
        },
        "Domain Expert": {
          "Critical Analyst": 0.894123378585286,
          "Creative Strategist": 0.8913411938945417,
          "Process Facilitator": 0.8264325187361288
        },
        "Creative Strategist": {
          "Critical Analyst": 0.8989040313685752,
          "Domain Expert": 0.9170665698434027,
          "Process Facilitator": 0.9632184613381203
        },
        "Process Facilitator": {
          "Critical Analyst": 0.9296893929835603,
          "Domain Expert": 0.9939198062276787,
          "Creative Strategist": 0.9949934633705586
        }
      },
      "mistake_admission_rates": {},
      "feedback_acceptance_rates": {},
      "trust_environment": "high"
    }
  }
}